Sections
| Title | Starting Page | Number of Pages |
|---|
| Table of Contents | 2 | 3 |
| List of Tables | 4 | 1 |
| List of Figures | 4 | 1 |
| Introduction | 5 | 1 |
| Global Markets Direct Report Coverage | 5 | 1 |
| Vitiligo Overview | 6 | 1 |
| Therapeutics Development | 7 | 1 |
| Pipeline Products for Vitiligo Overview | 7 | 1 |
| Vitiligo Therapeutics under Development by Companies | 8 | 1 |
| Vitiligo Pipeline Products Glance | 9 | 2 |
| Clinical Stage Products | 9 | 1 |
| Early Stage Products | 10 | 1 |
| Vitiligo Products under Development by Companies | 11 | 1 |
| Vitiligo Companies Involved in Therapeutics Development | 12 | 4 |
| Ache Laboratorios Farmaceuticos S/A | 12 | 1 |
| Biocon Limited | 13 | 1 |
| Bristol-Myers Squibb Company | 14 | 1 |
| Clinuvel Pharmaceuticals Limited | 15 | 1 |
| Vitiligo Therapeutics Assessment | 16 | 9 |
| Assessment by Monotherapy Products | 16 | 1 |
| Assessment by Target | 17 | 2 |
| Assessment by Mechanism of Action | 19 | 2 |
| Assessment by Route of Administration | 21 | 2 |
| Assessment by Molecule Type | 23 | 2 |
| Drug Profiles | 25 | 17 |
| abatacept Drug Profile | 25 | 5 |
| ACH-24 Drug Profile | 30 | 1 |
| afamelanotide Drug Profile | 31 | 8 |
| itolizumab Drug Profile | 39 | 2 |
| VLRX-001 Drug Profile | 41 | 1 |
| Vitiligo Dormant Projects | 42 | 1 |
| Vitiligo Product Development Milestones | 43 | 13 |
| Featured News &Press Releases | 43 | 1 |
| Dec 03, 2015: Positive preliminary results in Singaporean vitiligo study | 43 | 1 |
| Dec 03, 2015: Update on North American vitiligo program for SCENESSE | 44 | 1 |
| May 05, 2015: Clinuvel announces innovative melanocortin for new indications | 45 | 1 |
| Mar 20, 2015: SCENESSE vitiligo data presented at world s largest dermatology conference | 46 | 1 |
| Sep 19, 2014: SCENESSE vitiligo study results published in JAMA Dermatology | 47 | 1 |
| May 06, 2014: Clinuvel s Phase II vitiligo study commences in Singapore | 48 | 1 |
| Mar 20, 2014: SCENESSE data to feature at American Academy of Dermatology | 48 | 1 |
| Nov 04, 2013: Clinuvel to start a Phase II vitiligo study in Singapore | 49 | 1 |
| Sep 02, 2013: Five month study follow up shows SCENESSE combination treatment provided stable repigmentation in vitiligo patients | 50 | 1 |
| Mar 01, 2013: SCENESSE data to be presented at American Academy of Dermatology, San Gallicano Rare Disease conference | 51 | 1 |
| Dec 19, 2012: Clinuvel Pharma Announces Results From Phase IIa Pilot Study Of Scenesse In Vitiligo | 51 | 2 |
| Oct 16, 2012: Observations from Clinuvels US vitiligo study published | 53 | 1 |
| Mar 15, 2012: Observations from Clinuvels vitiligo and EPP programs being presented at the | 53 | 1 |
| Mar 02, 2011: Clinuvel Announces FDA Approval For Vitiligo Drug Trial | 54 | 2 |
| Appendix | 56 | 2 |
| Methodology | 56 | 1 |
| Coverage | 56 | 1 |
| Secondary Research | 56 | 1 |
| Primary Research | 56 | 1 |
| Expert Panel Validation | 56 | 1 |
| Contact Us | 56 | 1 |
| Disclaimer | 57 | 1 |